Fundraising Fox

S2G Investments2023 Investments

5 investments dated 2023 · listed companies and verified rows first · show all

ViAquaviaqua-t.comSep 2023✓ verified

ViAqua Therapeutics develops RNA-based solutions to treat diseases in aquaculture, specifically targeting viral pathogens like White Spot Shrimp Virus in shrimp through oral feed application.

AgTechAI & Machine LearningBiotechFoodTech

Shai Ufaz(CEO & Co-Founder)Shai Einbinder(Co-Founder)

Co-investorsIsrael Innovation AuthorityRabo VenturesTrendlines Group

Electric Hydrogeneh2.cominOct 2023 · $380M

Electric Hydrogen develops hydrogen production technology to support decarbonization.

Advanced ManufacturingCleantechClimate TechEnergyMassachusetts, US

Derek Warnick(Executive Officer)inDavid Eaglesham(Executive Officer, Director)inRaffi Garabedian(Executive Officer, Director)inDorian West(Founder)inMargaret Deane(Executive Officer)

BoardDipender Saluja(Director)

Co-investorsBreakthrough Energy VenturesCongruent VenturesEnergy Impact PartnersFifth WallPrelude Venturesbp ventures+6 more

ReelData AIreeldata.aiin𝕏Jan 2023 · $8M

ReelData AI provides an AI-powered software suite for land-based aquaculture farms to optimize feeding, monitor fish biomass, manage environmental conditions, and detect health issues.

AgTechAI & Machine LearningClimate TechIoTHalifax, CA

Mathew Zimola(Founder)

Co-investorsBuoyant Ventures Management, LlcTechstars

Solarea Biosolareabio.comMay 2023 · $15M

BiotechWaltham, US

ILISSA LARIMORE(Executive Officer)GERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)

BoardANULA JAYASURIYA(Director)inMATTHEW WALKER(Director)NEAL BHADKAMKAR(Director)in

Co-investorsOlive Tree CapitalRising TideBold Capital PartnersDigitalDx VenturesViking Global Investors

The Plant Based Seafood Co.eatmindblown.cominMar 2023

Mindblown makes plant-based seafood alternatives that arrive frozen and are ready to cook in minutes, made without palm oil.

ConsumerDirect to ConsumerFoodTech

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.